These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8869425)

  • 21. Iminodipropionitrile-induced dyskinesia in mice: striatal calcium channel changes and sensitivity to calcium channel antagonists.
    Bangalore R; Hawthorn M; Triggle DJ
    J Neurochem; 1991 Aug; 57(2):550-5. PubMed ID: 1649253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection by 2-deoxy-D-glucose against beta,beta'-iminodipropionitrile-induced neurobehavioral toxicity in mice.
    Tariq M; Khan HA; al Moutaery K; al Deeb S
    Exp Neurol; 1999 Jul; 158(1):229-33. PubMed ID: 10448436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurotransmitter and receptor alterations in the rat persistent dyskinesia model induced by iminodipropionitrile.
    Ogawa N; Mizukawa K; Haba K; Sato H
    Eur Neurol; 1990; 30 Suppl 1():31-40. PubMed ID: 1968833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histological insights in iminodipropionitrile-induced toxicity in rats.
    Ibrahim KE; Khan HA; Omer FA
    Exp Toxicol Pathol; 2014 Mar; 66(2-3):89-96. PubMed ID: 24332269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurochemical and neurobehavioral effects of neonatal administration of beta-N-methylamino-L-alanine and 3,3'-iminodipropionitrile.
    Dawson R; Marschall EG; Chan KC; Millard WJ; Eppler B; Patterson TA
    Neurotoxicol Teratol; 1998; 20(2):181-92. PubMed ID: 9536463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of location, severity, and dose response of proximal axonal lesions induced by 3,3'-iminodipropionitrile and deuterium substituted analogs.
    Denlinger RH; Anthony DC; Amarnath V; Graham DG
    J Neuropathol Exp Neurol; 1992 Nov; 51(6):569-76. PubMed ID: 1484287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative autoradiographic changes in 5-[3H]HT-labeled 5-HT1 serotonin receptors in discrete regions of brain in the rat model of persistent dyskinesias induced by iminodipropionitrile (IDPN).
    Przedborski S; Wright M; Fahn S; Cadet JL
    Neurosci Lett; 1990 Aug; 116(1-2):51-7. PubMed ID: 2259456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naltrexone inhibits the persistent spasmodic dyskinesia induced by chronic intraperitoneal administration of iminodipropionitrile (IDPN).
    Cadet JL; Braun TL
    Neuropeptides; 1986 Jul; 8(1):87-91. PubMed ID: 3762878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Administration of 3,3'-iminodipropionitrile to the rat results in region-dependent damage to the central nervous system at levels above the brain stem.
    Llorens J; Crofton KM; O'Callaghan JP
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1492-8. PubMed ID: 8510024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the effects of N-hydroxy-IDPN on the auditory, vestibular, and olfactory systems in rats.
    Crofton KM; Zhao X; Sayre LM; Genter MB
    Neurotoxicol Teratol; 1996; 18(3):297-303. PubMed ID: 8725642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonidine and prazosin block the iminodipropionitrile (IDPN)-induced spasmodic dyskinetic syndrome in mice.
    Cadet JL; Braun T; Freed WJ
    Pharmacol Biochem Behav; 1987 Apr; 26(4):791-5. PubMed ID: 3037570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The iminodipropionitrile (IDPN)-induced dyskinetic syndrome in mice: antagonism by the calcium channel antagonist nifedipine.
    Cadet JL; Taylor E; Freed WJ
    Pharmacol Biochem Behav; 1988 Feb; 29(2):381-5. PubMed ID: 2452450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of bimoclomol (N-[2-hydroxy-3-(1-piperidinyl) propoxy]-3 pyridine-carboximidoyl-chloride) on iminodipropionitrile-induced central effects.
    Tóth E; Gerevich Z; Dóda M; Lajtha A
    Neurochem Int; 1998 Dec; 33(6):513-8. PubMed ID: 10098720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced neurotoxicity of 3,3'-iminodipropionitrile following carbon tetrachloride pretreatment in the rat.
    Llorens J; Crofton KM
    Neurotoxicology; 1991; 12(3):583-94. PubMed ID: 1745441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The iminodipropionitrile (IDPN) model of persistent spasmodic dyskinesias: regional serotonin metabolism in rat brain.
    Cadet JL; Jackson-Lewis V; Fahn S
    Brain Res; 1988 Jul; 456(2):371-4. PubMed ID: 2463039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged neurobehavioral and visual effects of short-term exposure to 3,3'-iminodipropionitrile (IDPN) in rats.
    Moser VC; Boyes WK
    Fundam Appl Toxicol; 1993 Oct; 21(3):277-90. PubMed ID: 8258381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional changes in brain 5-HT1A serotonin receptors in the rat model of persistent spasmodic dyskinesias induced by iminodipropionitrile.
    Przedborski S; Wright M; Fahn S; Cadet JL
    Brain Res; 1989 Dec; 504(2):311-4. PubMed ID: 2532054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-nitro-L-arginine, a nitric oxide synthase inhibitor, aggravates iminodipropionitrile-induced neurobehavioral and vestibular toxicities in rats.
    Khan HA
    Exp Toxicol Pathol; 2012 Nov; 64(7-8):791-6. PubMed ID: 21388795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. beta,beta'-Iminodipropionitrile-induced persistent dyskinetic syndrome in mice is transiently modified by MPTP.
    Fornai F; Alessandri MG; Saginario A; Vaglini F; Corsini GU
    Brain Res; 1993 Mar; 605(1):93-100. PubMed ID: 7682144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased cortical serotonin-2 (5-HT-2) receptors in the iminodipropionitrile (IDPN)-model of persistent dyskinesia in the rat.
    Cadet JL; Rothman RB
    Neuropeptides; 1987; 10(2):175-80. PubMed ID: 3683772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.